Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.

The Journal of infectious diseases - 15 Jul 2004

Recsky Magdalena A, Brumme Zabrina L, Chan Keith J, Wynhoven Brian, Yip Benita, Dong Winnie W Y, Heath Katherine V, Montaner Julio S G, Levy Adrian R, Hogg Robert S, Harrigan P Richard

Abstract excerpt

BACKGROUND: The prevalence of antiretroviral resistance among persons enrolled in the centralized HIV/AIDS Drug Treatment Program in British Columbia, Canada, who had died between July 1997 and December 2001, was investigated, to determine the degree to which antiretroviral resistance contributed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to British Columbia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple, Viral

Share to HIV Protease

Share to HIV Protease Inhibitors

Share to HIV Reverse Transcriptase

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 15216463
DOI: 10.1086/422007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15216463-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.PMID 15216463Read ↗

Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use.Semantic proximity Read ↗

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.Semantic proximity Read ↗

The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.Semantic proximity Read ↗

Prevalence and Response to Antiretroviral Therapy of Non-B Subtypes of HIV in Antiretroviral-Naive Individuals in British ColumbiaSemantic proximity Read ↗

Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users.Semantic proximity Read ↗

Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.Semantic proximity Read ↗

Treatment limitations imposed by antiretroviral drug resistance mutations: implication for choices of first line regimens in resource-limited settings.Semantic proximity Read ↗

HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort.Semantic proximity Read ↗

Towards targeted screening for acute HIV infections in British Columbia.Semantic proximity Read ↗

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.